These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 24841104

  • 1. Vitamin K₂ therapy for postmenopausal osteoporosis.
    Iwamoto J.
    Nutrients; 2014 May 16; 6(5):1971-80. PubMed ID: 24841104
    [Abstract] [Full Text] [Related]

  • 2. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.
    Jiang Y, Zhang ZL, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW.
    Clin Interv Aging; 2014 May 16; 9():121-7. PubMed ID: 24426779
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Su S, He N, Men P, Song C, Zhai S.
    Osteoporos Int; 2019 Jun 16; 30(6):1175-1186. PubMed ID: 30734066
    [Abstract] [Full Text] [Related]

  • 4. Menatetrenone for the treatment of osteoporosis.
    Iwamoto J, Sato Y.
    Expert Opin Pharmacother; 2013 Mar 16; 14(4):449-58. PubMed ID: 23346882
    [Abstract] [Full Text] [Related]

  • 5. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients.
    Suzuki K, Tsuji S, Fukushima Y, Nakase T, Hamada M, Tomita T, Yoshikawa H.
    Mod Rheumatol; 2013 May 16; 23(3):450-5. PubMed ID: 22692649
    [Abstract] [Full Text] [Related]

  • 6. Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.
    Iwamoto J, Takeda T, Sato Y.
    Nutr Rev; 2006 Dec 16; 64(12):509-17. PubMed ID: 17274493
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
    Stevenson M, Lloyd-Jones M, Papaioannou D.
    Health Technol Assess; 2009 Sep 16; 13(45):iii-xi, 1-134. PubMed ID: 19818211
    [Abstract] [Full Text] [Related]

  • 9. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.
    Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H.
    J Bone Miner Metab; 2008 Sep 16; 26(3):260-4. PubMed ID: 18470667
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis.
    Kasukawa Y, Miyakoshi N, Ebina T, Aizawa T, Hongo M, Nozaka K, Ishikawa Y, Saito H, Chida S, Shimada Y.
    J Bone Miner Metab; 2014 May 16; 32(3):290-7. PubMed ID: 23846118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M.
    Gynecol Endocrinol; 2006 Aug 16; 22(8):455-9. PubMed ID: 17012108
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
    Ma ML, Ma ZJ, He YL, Sun H, Yang B, Ruan BJ, Zhan WD, Li SX, Dong H, Wang YX.
    Front Public Health; 2022 Aug 16; 10():979649. PubMed ID: 36033779
    [Abstract] [Full Text] [Related]

  • 20. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E.
    Osteoporos Int; 2013 Sep 16; 24(9):2499-507. PubMed ID: 23525894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.